Skip to Content
Merck
  • A sleep-active basalocortical pathway crucial for generation and maintenance of chronic pain.

A sleep-active basalocortical pathway crucial for generation and maintenance of chronic pain.

Nature neuroscience (2023-01-24)
Hang Zhou, Miao Li, Ruohe Zhao, Linlin Sun, Guang Yang
ABSTRACT

Poor sleep is associated with the risk of developing chronic pain, but how sleep contributes to pain chronicity remains unclear. Here we show that following peripheral nerve injury, cholinergic neurons in the anterior nucleus basalis (aNB) of the basal forebrain are increasingly active during nonrapid eye movement (NREM) sleep in a mouse model of neuropathic pain. These neurons directly activate vasoactive intestinal polypeptide-expressing interneurons in the primary somatosensory cortex (S1), causing disinhibition of pyramidal neurons and allodynia. The hyperactivity of aNB neurons is caused by the increased inputs from the parabrachial nucleus (PB) driven by the injured peripheral afferents. Inhibition of this pathway during NREM sleep, but not wakefulness, corrects neuronal hyperactivation and alleviates pain. Our results reveal that the PB-aNB-S1 pathway during sleep is critical for the generation and maintenance of chronic pain. Inhibiting this pathway during the sleep phase could be important for treating neuropathic pain.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Clozapine N-oxide
Sigma-Aldrich
Anti-Calcitonin Gene-Related Peptide antibody, Mouse monoclonal, clone 4901, purified from hybridoma cell culture
Sigma-Aldrich
Monoclonal Anti-mCherry antibody produced in mouse, clone GT844, affinity isolated antibody
Sigma-Aldrich
Anti-NeuN Antibody, clone A60, clone A60, Chemicon®, from mouse
Sigma-Aldrich
Anti-Choline Acetyltransferase Antibody, Chemicon®, from goat